Dyspnea clinical trials at UC Cancer
1 research study open to eligible people
Standard of Care Therapy With/Without Stereotactic Radiosurgery(SBRT) and/or Surgery to treat patients with breast cancer
“Is standard of care therapy more effective when SBRT and/or surgery is added to the treatment of limited metastatic breast cancer?”
open to eligible females ages 18 years and up
This randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone in treating patients with breast cancer that has spread to one or two locations in the body (limited metastatic) that are previously untreated. Standard of care therapy comprising chemotherapy, hormonal therapy, biological therapy, and others may help stop the spread of tumor cells. Radiation therapy and/or surgery is usually only given with standard of care therapy to relieve pain; however, in patients with limited metastatic breast cancer, stereotactic radiosurgery, also known as stereotactic body radiation therapy, may be able to send x-rays directly to the tumor and cause less damage to normal tissue and surgery may be able to effectively remove the metastatic tumor cells. It is not yet known whether standard of care therapy is more effective with stereotactic radiosurgery and/or surgery in treating limited metastatic breast cancer.
at UC Davis UC Irvine UCSD